青海地区肝泡型棘球蚴病治疗方案的研究进展

ISSN:2705-098X(P)

EISSN:2705-0505(O)

语言:中文

作者
贺景昊,吴世乐
文章摘要
肝泡型棘球蚴病(hepatic alveolar echinococcosis,HAE)是青海地区高发的致死性寄生虫病,因其侵袭性生长特性及晚期高死亡率备受关注。近年来,青海地区通过技术革新与综合防控策略显著提升了HAE诊疗水平。本文现就肝泡型棘球蚴病的诊断、治疗现状的应用、难点、进展作一综述。
文章关键词
肝泡型棘球蚴病;腹腔镜肝切除;微波消融;阿苯达唑;综合防控
参考文献
[1] 陈骏,温浩.肝棘球蚴病的诊断与治疗进展[J].东南大学学报(医学版),2018,37(05):929-934. [2] Nunnari G,Pinzone MR,Gruttadauria S,Celesia BM,Madeddu G,Malaguarnera G,Pavone P,Cappellani A,Cacopardo B.Hepatic echinococcosis:clinical and therapeutic aspects.World J Gastroenterol.2012 Apr 7;18(13):1448-58. [3] 陈哲宇.泡型肝包虫病的外科治疗现状[J].中国普外基础与临床杂志,2016,23(05):513-516. [4] 黄国强,叶谢智华,郭亚民,等.青海地区终末期肝泡型包虫病的治疗现状及展望[J].中华临床医师杂志(电子版),2021, 15(03):209-212. [5] 刘海刚,东小鸽,周攀登,等.肝棘球蚴病的诊断进展[J].中国普外基础与临床杂志,2024,31(10):1210-1220. [6] 四川省包虫病临床医学研究中心,四川省医师协会包虫病专业委员会.泡型肝包虫病诊疗专家共识(2020版)[J].中国普外基础与临床杂志,2020,27(01):13-17. [7] Fathi S,Jalousian F,Hosseini SH,Parsa H,Kordafshari S.A Study of Cross-Reactivity Between Recombinant EPC1 Antigen of Echinococcus granulosus in Serum from Patients with Confirmed Cystic Echinococcosis Infection and Other Parasitic Infections.Am J Trop Med Hyg.2016 Jun 1;94(6):1313-7. [8] 邱逸闻,庞华胜,沈舒,等.肝泡型棘球蚴病的外科治疗策略[J].中国普外基础与临床杂志,2024,31(10):1153-1159. [9] Kamiyama T.Recent advances in surgical strategies for alveolar echinococcosis of the liver.Surg Today.2020 Nov;50(11):1360-1367. [10] 李铭,温浩.腹腔镜手术治疗肝泡型棘球蚴病的应用进展[J].腹腔镜外科杂志,2023,28(12):948-953. [11] Wan L,Ran B,Aji T,Shalayiadang P,Jiang T,Shao Y,Wen H.Laparoscopic hepatectomy for the treatment of hepatic alveolar echinococcosis.Parasite.2021;28:5. [12] Gloor S,Candinas D,Beldi G,Lachenmayer A.Laparoscopic resection of hepatic alveolar echinococcosis:A single-center experience. PLoS Negl Trop Dis.2022 Sep 6;16(9):e0010708. [13] Meloni MF,Chiang J,Laeseke PF,Dietrich CF,Sannino A,Solbiati M,Nocerino E,Brace CL,Lee FT Jr.Microwave ablation in primary and secondary liver tumours:technical and clinical approaches.Int J Hyperthermia.2017 Feb;33(1):15-24. [14] 王文涛,杨先伟.四川省肝泡型包虫病消融治疗技术规范[J].中国普外基础与临床杂志,2018,25(11):1304-1307. [15] Deng X,Wang JJ,Wang ZX,Fan HN,Wang HJ,Huang HS,Wang KQ,Yang XZ,Han JW,Cairang Y.Effectiveness and safety of ultrasound-guided percutaneous microwave ablation for hepatic alveolar echinococcosis.BMC Med Imaging.2022 Feb 12;22(1):27. [16] 温浩,董家鸿,张金辉,等.体外肝切除联合自体肝移植治疗肝泡型包虫病.中华消化外科杂志,2011,10(2):148-149. [17] Wen H,Dong JH,Zhang JH,Zhao JM,Shao YM,Duan WD,Liang YR,Ji XW,Tai QW,Aji T,Li T.Ex vivo liver resection followed by autotransplantation for end-stage hepatic alveolar echinococcosis.Chin Med J(Engl).2011 Sep;124(18):2813-7.PMID:22040485. [18] 蒋铁民.肝终末期泡型棘球蚴病自体肝移植流出道重建关键技术和肝再生的动物实验研究[D].新疆医科大学,2023. [19] 姜继强.经皮经肝胆管穿刺置管引流术联合介入手术治疗老年恶性梗阻性黄疸的临床效果分析[J].中国实用医药, 2023,18(19):45-48. [20] Horton J.Albendazole for the treatment of echinococcosis.Fundam Clin Pharmacol.2003 Apr;17(2):205-12. [21] Burkert S,Peters L,Bloehdorn J,Grüner B.Salvage Therapy for Alveolar Echinococcosis-A Case Series.Pathogens.2022 Mar 9;11(3):333. [22] Tappe D,Müller A,Frosch M,Stich A.Limitations of amphotericin B and nitazoxanide in the treatment of alveolar echinococcosis.Ann Trop Med Parasitol.2009 Mar;103(2):177-81. [23] Küster T,Stadelmann B,Hermann C,Scholl S,Keiser J,Hemphill A.In vitro and in vivo efficacies of mefloquine-based treatment against alveolar echinococcosis.Antimicrob Agents Chemother.2011 Feb;55(2):713-21. [24] Autier B,Robert-Gangneux F,Dion S.Chemotherapy for the treatment of alveolar echinococcosis:Where are we?Parasite.2024;31:56.
Full Text:
DOI